COVID-19 Impact on Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-kidneyrenal-fibrosis-treatment-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Galectin Therapeutics
- Merck & Co.
- F. Hoffman-La Roche Ltd.
- Pfizer Inc.
- InterMune Inc.
- ProMetic Life-Sciences Inc.
- La Jolla Pharmaceutical Company
- Genzyme Corporation
- BioLine Rx Ltd
- Angiotensin II Receptor Blockers (ARBs)
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Pirfenidone
- Renin Inhibitors
- Vasopeptidase Inhibitors
- Commercial/Private Hospitals
- Public Health Hospitals
- Clinics
- Home Treatment
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
- To present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Angiotensin II Receptor Blockers (ARBs)
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Pirfenidone
1.4.5 Renin Inhibitors
1.4.6 Vasopeptidase Inhibitors
1.5 Market by Application
1.5.1 Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Commercial/Private Hospitals
1.5.3 Public Health Hospitals
1.5.4 Clinics
1.5.5 Home Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Kidney/Renal Fibrosis Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Kidney/Renal Fibrosis Treatment Industry
1.6.1.1 Kidney/Renal Fibrosis Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Kidney/Renal Fibrosis Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Kidney/Renal Fibrosis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Kidney/Renal Fibrosis Treatment Market Perspective (2015-2026)
2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Regions
2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Kidney/Renal Fibrosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Kidney/Renal Fibrosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Kidney/Renal Fibrosis Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Kidney/Renal Fibrosis Treatment Players by Market Size
3.1.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio
3.2.1 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Kidney/Renal Fibrosis Treatment Revenue in 2019
3.3 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served
3.4 Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
3.5 Date of Enter into Kidney/Renal Fibrosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2021-2026)
5 KIDNEY/RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
5.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
6.2 Kidney/Renal Fibrosis Treatment Key Players in North America (2019-2020)
6.3 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
6.4 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
7.2 Kidney/Renal Fibrosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
7.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
8.2 Kidney/Renal Fibrosis Treatment Key Players in China (2019-2020)
8.3 China Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
8.4 China Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
9.2 Kidney/Renal Fibrosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
9.4 Japan Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
10.2 Kidney/Renal Fibrosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
11.2 Kidney/Renal Fibrosis Treatment Key Players in India (2019-2020)
11.3 India Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
11.4 India Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
12.2 Kidney/Renal Fibrosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Galectin Therapeutics
13.1.1 Galectin Therapeutics Company Details
13.1.2 Galectin Therapeutics Business Overview and Its Total Revenue
13.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Introduction
13.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020))
13.1.5 Galectin Therapeutics Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview and Its Total Revenue
13.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Introduction
13.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 F. Hoffman-La Roche Ltd.
13.3.1 F. Hoffman-La Roche Ltd. Company Details
13.3.2 F. Hoffman-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Introduction
13.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.3.5 F. Hoffman-La Roche Ltd. Recent Development
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Company Details
13.4.2 Pfizer Inc. Business Overview and Its Total Revenue
13.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Introduction
13.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.4.5 Pfizer Inc. Recent Development
13.5 InterMune Inc.
13.5.1 InterMune Inc. Company Details
13.5.2 InterMune Inc. Business Overview and Its Total Revenue
13.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Introduction
13.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.5.5 InterMune Inc. Recent Development
13.6 ProMetic Life-Sciences Inc.
13.6.1 ProMetic Life-Sciences Inc. Company Details
13.6.2 ProMetic Life-Sciences Inc. Business Overview and Its Total Revenue
13.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Introduction
13.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.6.5 ProMetic Life-Sciences Inc. Recent Development
13.7 La Jolla Pharmaceutical Company
13.7.1 La Jolla Pharmaceutical Company Company Details
13.7.2 La Jolla Pharmaceutical Company Business Overview and Its Total Revenue
13.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Introduction
13.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.7.5 La Jolla Pharmaceutical Company Recent Development
13.8 Genzyme Corporation
13.8.1 Genzyme Corporation Company Details
13.8.2 Genzyme Corporation Business Overview and Its Total Revenue
13.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Introduction
13.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.8.5 Genzyme Corporation Recent Development
13.9 BioLine Rx Ltd
13.9.1 BioLine Rx Ltd Company Details
13.9.2 BioLine Rx Ltd Business Overview and Its Total Revenue
13.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Introduction
13.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.9.5 BioLine Rx Ltd Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Angiotensin II Receptor Blockers (ARBs)
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Pirfenidone
1.4.5 Renin Inhibitors
1.4.6 Vasopeptidase Inhibitors
1.5 Market by Application
1.5.1 Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Commercial/Private Hospitals
1.5.3 Public Health Hospitals
1.5.4 Clinics
1.5.5 Home Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Kidney/Renal Fibrosis Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Kidney/Renal Fibrosis Treatment Industry
1.6.1.1 Kidney/Renal Fibrosis Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Kidney/Renal Fibrosis Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Kidney/Renal Fibrosis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Kidney/Renal Fibrosis Treatment Market Perspective (2015-2026)
2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Regions
2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Kidney/Renal Fibrosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Kidney/Renal Fibrosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Kidney/Renal Fibrosis Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Kidney/Renal Fibrosis Treatment Players by Market Size
3.1.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio
3.2.1 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Kidney/Renal Fibrosis Treatment Revenue in 2019
3.3 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served
3.4 Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
3.5 Date of Enter into Kidney/Renal Fibrosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2021-2026)
5 KIDNEY/RENAL FIBROSIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
5.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
6.2 Kidney/Renal Fibrosis Treatment Key Players in North America (2019-2020)
6.3 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
6.4 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
7.2 Kidney/Renal Fibrosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
7.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
8.2 Kidney/Renal Fibrosis Treatment Key Players in China (2019-2020)
8.3 China Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
8.4 China Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
9.2 Kidney/Renal Fibrosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
9.4 Japan Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
10.2 Kidney/Renal Fibrosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
11.2 Kidney/Renal Fibrosis Treatment Key Players in India (2019-2020)
11.3 India Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
11.4 India Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Kidney/Renal Fibrosis Treatment Market Size (2015-2020)
12.2 Kidney/Renal Fibrosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Galectin Therapeutics
13.1.1 Galectin Therapeutics Company Details
13.1.2 Galectin Therapeutics Business Overview and Its Total Revenue
13.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Introduction
13.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020))
13.1.5 Galectin Therapeutics Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview and Its Total Revenue
13.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Introduction
13.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 F. Hoffman-La Roche Ltd.
13.3.1 F. Hoffman-La Roche Ltd. Company Details
13.3.2 F. Hoffman-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Introduction
13.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.3.5 F. Hoffman-La Roche Ltd. Recent Development
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Company Details
13.4.2 Pfizer Inc. Business Overview and Its Total Revenue
13.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Introduction
13.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.4.5 Pfizer Inc. Recent Development
13.5 InterMune Inc.
13.5.1 InterMune Inc. Company Details
13.5.2 InterMune Inc. Business Overview and Its Total Revenue
13.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Introduction
13.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.5.5 InterMune Inc. Recent Development
13.6 ProMetic Life-Sciences Inc.
13.6.1 ProMetic Life-Sciences Inc. Company Details
13.6.2 ProMetic Life-Sciences Inc. Business Overview and Its Total Revenue
13.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Introduction
13.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.6.5 ProMetic Life-Sciences Inc. Recent Development
13.7 La Jolla Pharmaceutical Company
13.7.1 La Jolla Pharmaceutical Company Company Details
13.7.2 La Jolla Pharmaceutical Company Business Overview and Its Total Revenue
13.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Introduction
13.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.7.5 La Jolla Pharmaceutical Company Recent Development
13.8 Genzyme Corporation
13.8.1 Genzyme Corporation Company Details
13.8.2 Genzyme Corporation Business Overview and Its Total Revenue
13.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Introduction
13.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.8.5 Genzyme Corporation Recent Development
13.9 BioLine Rx Ltd
13.9.1 BioLine Rx Ltd Company Details
13.9.2 BioLine Rx Ltd Business Overview and Its Total Revenue
13.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Introduction
13.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020)
13.9.5 BioLine Rx Ltd Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Kidney/Renal Fibrosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue
Table 3. Ranking of Global Top Kidney/Renal Fibrosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 6. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Pirfenidone
Table 8. Key Players of Renin Inhibitors
Table 9. Key Players of Vasopeptidase Inhibitors
Table 10. COVID-19 Impact Global Market: (Four Kidney/Renal Fibrosis Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Kidney/Renal Fibrosis Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Kidney/Renal Fibrosis Treatment Players to Combat Covid-19 Impact
Table 15. Global Kidney/Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2015-2020)
Table 19. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Kidney/Renal Fibrosis Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Kidney/Renal Fibrosis Treatment Players
Table 26. Global Kidney/Renal Fibrosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Kidney/Renal Fibrosis Treatment Market Share by Players (2015-2020)
Table 28. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019)
Table 29. Global Kidney/Renal Fibrosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
Table 32. Date of Enter into Kidney/Renal Fibrosis Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Kidney/Renal Fibrosis Treatment Market Size Share by Type (2015-2020)
Table 36. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2015-2020)
Table 38. Global Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 42. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 44. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 48. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 50. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 54. China Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 56. China Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 60. Japan Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 62. Japan Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 66. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 72. India Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 74. India Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 78. Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 82. Galectin Therapeutics Company Details
Table 83. Galectin Therapeutics Business Overview
Table 84. Galectin Therapeutics Product
Table 85. Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 86. Galectin Therapeutics Recent Development
Table 87. Merck & Co. Company Details
Table 88. Merck & Co. Business Overview
Table 89. Merck & Co. Product
Table 90. Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 91. Merck & Co. Recent Development
Table 92. F. Hoffman-La Roche Ltd. Company Details
Table 93. F. Hoffman-La Roche Ltd. Business Overview
Table 94. F. Hoffman-La Roche Ltd. Product
Table 95. F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 96. F. Hoffman-La Roche Ltd. Recent Development
Table 97. Pfizer Inc. Company Details
Table 98. Pfizer Inc. Business Overview
Table 99. Pfizer Inc. Product
Table 100. Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 101. Pfizer Inc. Recent Development
Table 102. InterMune Inc. Company Details
Table 103. InterMune Inc. Business Overview
Table 104. InterMune Inc. Product
Table 105. InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 106. InterMune Inc. Recent Development
Table 107. ProMetic Life-Sciences Inc. Company Details
Table 108. ProMetic Life-Sciences Inc. Business Overview
Table 109. ProMetic Life-Sciences Inc. Product
Table 110. ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 111. ProMetic Life-Sciences Inc. Recent Development
Table 112. La Jolla Pharmaceutical Company Company Details
Table 113. La Jolla Pharmaceutical Company Business Overview
Table 114. La Jolla Pharmaceutical Company Product
Table 115. La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 116. La Jolla Pharmaceutical Company Recent Development
Table 117. Genzyme Corporation Business Overview
Table 118. Genzyme Corporation Product
Table 119. Genzyme Corporation Company Details
Table 120. Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 121. Genzyme Corporation Recent Development
Table 122. BioLine Rx Ltd Company Details
Table 123. BioLine Rx Ltd Business Overview
Table 124. BioLine Rx Ltd Product
Table 125. BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 126. BioLine Rx Ltd Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 1. Kidney/Renal Fibrosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue
Table 3. Ranking of Global Top Kidney/Renal Fibrosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 6. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Pirfenidone
Table 8. Key Players of Renin Inhibitors
Table 9. Key Players of Vasopeptidase Inhibitors
Table 10. COVID-19 Impact Global Market: (Four Kidney/Renal Fibrosis Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Kidney/Renal Fibrosis Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Kidney/Renal Fibrosis Treatment Players to Combat Covid-19 Impact
Table 15. Global Kidney/Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2015-2020)
Table 19. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Kidney/Renal Fibrosis Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Kidney/Renal Fibrosis Treatment Players
Table 26. Global Kidney/Renal Fibrosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Kidney/Renal Fibrosis Treatment Market Share by Players (2015-2020)
Table 28. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019)
Table 29. Global Kidney/Renal Fibrosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
Table 32. Date of Enter into Kidney/Renal Fibrosis Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Kidney/Renal Fibrosis Treatment Market Size Share by Type (2015-2020)
Table 36. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2015-2020)
Table 38. Global Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 42. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 44. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 48. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 50. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 54. China Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 56. China Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 60. Japan Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 62. Japan Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 66. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 72. India Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 74. India Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Kidney/Renal Fibrosis Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Kidney/Renal Fibrosis Treatment Market Share (2019-2020)
Table 78. Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Kidney/Renal Fibrosis Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Kidney/Renal Fibrosis Treatment Market Share by Application (2015-2020)
Table 82. Galectin Therapeutics Company Details
Table 83. Galectin Therapeutics Business Overview
Table 84. Galectin Therapeutics Product
Table 85. Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 86. Galectin Therapeutics Recent Development
Table 87. Merck & Co. Company Details
Table 88. Merck & Co. Business Overview
Table 89. Merck & Co. Product
Table 90. Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 91. Merck & Co. Recent Development
Table 92. F. Hoffman-La Roche Ltd. Company Details
Table 93. F. Hoffman-La Roche Ltd. Business Overview
Table 94. F. Hoffman-La Roche Ltd. Product
Table 95. F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 96. F. Hoffman-La Roche Ltd. Recent Development
Table 97. Pfizer Inc. Company Details
Table 98. Pfizer Inc. Business Overview
Table 99. Pfizer Inc. Product
Table 100. Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 101. Pfizer Inc. Recent Development
Table 102. InterMune Inc. Company Details
Table 103. InterMune Inc. Business Overview
Table 104. InterMune Inc. Product
Table 105. InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 106. InterMune Inc. Recent Development
Table 107. ProMetic Life-Sciences Inc. Company Details
Table 108. ProMetic Life-Sciences Inc. Business Overview
Table 109. ProMetic Life-Sciences Inc. Product
Table 110. ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 111. ProMetic Life-Sciences Inc. Recent Development
Table 112. La Jolla Pharmaceutical Company Company Details
Table 113. La Jolla Pharmaceutical Company Business Overview
Table 114. La Jolla Pharmaceutical Company Product
Table 115. La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 116. La Jolla Pharmaceutical Company Recent Development
Table 117. Genzyme Corporation Business Overview
Table 118. Genzyme Corporation Product
Table 119. Genzyme Corporation Company Details
Table 120. Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 121. Genzyme Corporation Recent Development
Table 122. BioLine Rx Ltd Company Details
Table 123. BioLine Rx Ltd Business Overview
Table 124. BioLine Rx Ltd Product
Table 125. BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2015-2020) (Million US$)
Table 126. BioLine Rx Ltd Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Kidney/Renal Fibrosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Angiotensin II Receptor Blockers (ARBs) Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Pirfenidone Features
Figure 5. Renin Inhibitors Features
Figure 6. Vasopeptidase Inhibitors Features
Figure 7. Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2020 VS 2026
Figure 8. Commercial/Private Hospitals Case Studies
Figure 9. Public Health Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Home Treatment Case Studies
Figure 12. Kidney/Renal Fibrosis Treatment Report Years Considered
Figure 13. Global Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Kidney/Renal Fibrosis Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Kidney/Renal Fibrosis Treatment Market Share by Players in 2019
Figure 18. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Kidney/Renal Fibrosis Treatment Revenue in 2019
Figure 20. North America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Galectin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 29. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 31. F. Hoffman-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 35. InterMune Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 37. ProMetic Life-Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 39. La Jolla Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 41. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 43. BioLine Rx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Figure 1. Global Kidney/Renal Fibrosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Angiotensin II Receptor Blockers (ARBs) Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Pirfenidone Features
Figure 5. Renin Inhibitors Features
Figure 6. Vasopeptidase Inhibitors Features
Figure 7. Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2020 VS 2026
Figure 8. Commercial/Private Hospitals Case Studies
Figure 9. Public Health Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Home Treatment Case Studies
Figure 12. Kidney/Renal Fibrosis Treatment Report Years Considered
Figure 13. Global Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Kidney/Renal Fibrosis Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Kidney/Renal Fibrosis Treatment Market Share by Players in 2019
Figure 18. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Kidney/Renal Fibrosis Treatment Revenue in 2019
Figure 20. North America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Galectin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 29. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 31. F. Hoffman-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 35. InterMune Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 37. ProMetic Life-Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 39. La Jolla Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 41. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 43. BioLine Rx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed